We estimate a data-driven signature of de novo Parkinson's disease progression as a sequence of disease events. We show that clinical decline in classic markers precedes grey-matter and white-matter neurodegeneration estimated from T1-weighted MRI and diffusion-weighted MRI. Using only cross-sectional data from the PPMI data set, we show model utility for fine-grained staging/stratification of patients, which holds promise for future clinical applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords